US |
Mashberg et al45 (ID8) | 0.8 (0.4 to 1.9) | 0 (0 to 0.5) | 0 (0 to 145) |
Stockwell and Lyman46 (ID10) | 11.2 (4.1 to 30.7) | 28% (10.5 to 53) | 1224 (461 to 2324) |
Winn et al47 (ID13) | 4.2 (2.6 to 6.7) | 1.9% (0.9 to 3.3) | 30 (15 to 54) |
Sweden |
Lewin et al48 (ID19) (men only) | 3.3 (0.8 to 12.0) | 32% (0 to 69) | 28 (0 to 61) |
Schildt et al49 (ID20) (men only) | 0.7 (0.4 to 1.1) | 0 (0 to 2) | 0 (0 to 2) |
India |
Diskshit and Kanhere52 (ID24) | 5.8 (3.6 to 9.5) | 51% (36 to 65) | 23768 (16838 to 30152) |
Rao et al54 (ID26) | 2.6 (2.0 to 3.4) | 27% (19 to 34) | 12270 (8818 to 15903) |
Sankaranarayan et al12 (ID28) | 6.9 (2.8 to 16.8) | 56% (28 to 78) | 26138 (13283 to 35942) |